US03836N1037 - Common Stock
APTINYX INC
NASDAQ:APTX (5/18/2023, 7:22:26 PM)
After market: 0.074 +0.01 (+21.31%)0.061
-0.04 (-39%)
Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. The company is headquartered in Evanston, Illinois and currently employs 12 full-time employees. The company went IPO on 2018-06-21. The firm is focused on the discovery, development, and commercialization of proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. The firm focuses on targeting and modulating N-methyl-D-aspartate receptors, (NMDArs), which are vital to the normal and effective function of the brain and nervous system. The firm's NYX-783 is in Phase 1 clinical development for the treatment of opioid use disorder (OUD), and in preclinical development for the treatment of alcohol use disorder. NYX-783 modulates NMDA receptors to increase glutamatergic activity in key regions and may act to enhance extinction learning and alleviate the emotional symptoms of opioid withdrawal. The firm's NMDAr modulator discovery platform builds on NMDAr biology. The platform has the potential to develop into a broad pipeline and product portfolio across an array of disorders of the brain and nervous system.
APTINYX INC
1801 Maple Ave Ste 4300
Evanston ILLINOIS 60201
P: 18478710377.0
CEO: Norbert G. Riedel
Employees: 12
Website: https://www.aptinyx.com/
It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!
AMC Entertainment (AMC) stock is in the news after the movie theater company announced it will launch its own line of popcorn at Walmart.
AdaptHealth (AHCO) stock is falling on Tuesday following the release of the company's earnings report for the fourth quarter of 2022.
Aptinyx (APTX) stock is taking a beating on Tuesday after the company revealed poor results from a Phase 2 clinical trial.
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!
Here you can normally see the latest stock twits on APTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: